Recalls for Baxter International Inc.

0.9 Percent Sodium Chloride Injection, USP (AUTO-C) by Baxter International: Recall - Potential For Leaking Containers, Particulate Matter and Missing Port
07/31/2015 Medical Recall

Leaking containers, particulate matter and missing port protectors could result in contamination of the solution. If not detected, this could lead to a bloodstream infection or other serious adverse health consequences.

  • Company:
    Baxter International Inc.
Baxter Initiates Voluntary Nationwide Recall Of One Lot Of Iv Solution Due To The Potential For Leaking Containers, Particulate Matter And Missing Port Protectors
07/31/2015 Food Recall

DEERFIELD, Ill., July 30, 2015 - Baxter International Inc. announced today it is voluntarily recalling one lot of intravenous (IV) solution to the hospital/user level due to the potential for leaking containers, particulate matter and missing port protectors. Baxter was made aware of these issues through customer complaints.

  • Company:
    Baxter International Inc.
  • Problem
    Undeclared Sibutramine, Desmethylsibutramine, And Phenolphthalein.
Baxter Initiates Voluntary Recall Of Two Lots Of IV Solutions Due To The Potential Presence Of Particulate Matter
07/20/2015 Food Recall

Baxter International Inc. announced today it is voluntarily recalling two lots of intravenous (IV) solutions to the hospital/user level due to the potential presence of particulate matter. The particulate matter in each case was determined to be an insect and was identified as a result of a customer complaint.

  • Company:
    Baxter International Inc.
  • Problem
    Suffocation And Choking Hazards
0.9 Percent Sodium Chloride Injection, USP, 50mL and 100mL by Baxter: Recall - Particulate Matter
07/20/2015 Medical Recall

Injecting a product containing particulate matter, in the absence of in-line filtration, may result in blockage of blood vessels, which can result in stroke, heart attack or damage to other organs.

  • Company:
    Baxter International Inc.
Baxter Initiates Voluntary Recall of Select Product Codes of Peripheral Vascular Patch
06/03/2015 Food Recall

Baxter International Inc. announced today it is voluntarily recalling four product codes of its VASCU-GUARD Peripheral Vascular Patch. Baxter received customer complaints of difficulty in distinguishing the smooth from rough surface of the VASCU-GUARD patch as described in the labeled instructions for use.

  • Company:
    Baxter International Inc.
  • Problem
    Deviation in the surface texture of the vascular patch in a new packaging configuration
Vascu-Guard Peripheral Vascular Patch by Baxter: Recall - Difficulty Distinguishing the Smooth from Rough Surface
06/03/2015 Medical Recall

Incorrect orientation of the patch with the rough side toward the bloodstream may increase the risk of vessel thrombosis and/or embolism. Posted 06/03/2015

  • Company:
    Baxter International Inc.
Intravenous (IV) Solutions (Select Lots) by Baxter: Recall - Potential Presence of Particulate Matter
04/10/2015 Medical Recall

Particles in IV solutions may cause: local vein irritation, inflammatory reaction, aggravation of preexisting infections, allergic reactions, and systemic embolization.

  • Company:
    Baxter International Inc.
Baxter Initiates Voluntary Recall of Select Lots of IV Solutions Due to the Potential Presence of Particulate Matter
04/10/2015 Food Recall

Baxter International Inc. announced today it is voluntarily recalling select lots of intravenous (IV) solutions to the hospital/user level due to the potential presence of particulate matter. Intravenous administration of a solution containing sterile particulate matter may lead to adverse health consequences.

  • Company:
    Baxter International Inc.
  • Problem
    Particulate Matter
0.9 Percent Sodium Chloride Injection USP in 100 mL MINI-BAG PLUS Container by Baxter: Recall - Particulate Matter
12/16/2014 Medical Recall

Intravenous administration of a solution containing particulate matter may lead to local vein irritation, inflammatory reaction, aggravation of preexisting infections, allergic reactions, and systemic embolization.

  • Company:
    Baxter International Inc.
Baxter Voluntarily Initiates U.S. Recall of Two Lots of Sodium Chloride Injection, USP Due to the Presence of Particulate Matter
12/15/2014 Food Recall

Baxter International Inc. announced today it voluntarily initiated a recall in the United States of two lots of 0.9% Sodium Chloride Injection USP in 100 mL MINI-BAG PLUS Container to the hospital/user level. The recall is being initiated as a result of two complaints (one per lot) of particulate matter that was identified as a fragment of the frangible from the vial adapter.

  • Company:
    Baxter International Inc.
  • Problem
    Crash Hazard (Recall Alert)
Highly Concentrated Potassium Chloride Injection, 10 mEq per 100 mL by Baxter: Recall - Mislabeled Overpouch
11/21/2014 Medical Recall

Administration of a dose lower than intended, especially in patients prone to severe electrolyte imbalance, may lead to serious, life-threatening adverse health consequences.

  • Company:
    Baxter International Inc.
Baxter Initiate Voluntary Recall of One Lot of Highly COncentrated Potassium Chloride Injection In The U.S. Due to Mislabeled Overpouch
11/21/2014 Food Recall

Baxter International Inc. is voluntarily recalling one lot of Highly Concentrated Potassium Chloride Injection, 10 mEq per 100 mL to the user level due to a complaint of mislabeling of the overpouch. The inability to detect this overpouch mislabeling at the point of care may result in the administration of a dose lower than intended. In the high-risk patient population – patients prone to severe electrolyte imbalance – this hazardous situation may lead to serious, life-threatening adverse health consequences

  • Company:
    Baxter International Inc.
  • Problem
    Overheating And Burn Hazards
Baxter Initiates Voluntary Recall of Two Lots of Intravia Containers in the U.S. and Canada
10/25/2014 Food Recall

Baxter International Inc. announced today it is voluntarily recalling two lots of INTRAVIA containers in the U.S. and Canada due to complaints received for particulate matter found inside the fluid path. Intravenous administration of a solution containing sterile particulate matter may lead to adverse health consequences.

  • Company:
    Baxter International, Inc.
  • Problem
    Particulate Matter
Potassium Chloride Injection (Baxter): Recall - Shipping Carton Mislabeling
09/17/2014 Medical Recall

Potential risk of medication error or delay in therapy for patients that require high concentration potassium chloride.

  • Company:
    Baxter International Inc.
Dianeal Low Calcium (2.5mEq/L) Peritoneal Dialysis Solution with 2.5 Percent Dextrose 5000mL (Ambu-Flex II): Recall - Presence of Particulate Matter
08/15/2014 Medical Recall

Particulate matter could potentially serve as a focal point for infection should any pre-existing peritonitis exist, and may lead to a fatal outcome.

  • Company:
    Baxter International Inc.
Baxter Initiates Voluntary Worldwide Recall Of Four Lots Of IV Solutions Due To The Presence Of Particulate Matter
07/17/2014 Food Recall

Baxter International Inc. announced today it is voluntarily recalling four lots of intravenous (IV) solutions to the hospital/user level. These products have been found to contain particulate matter identified as cellulosic fibers and/or plastics. Baxter received four complaints over a period of six months from customers whose visual inspection identified the appearance of visible particulate matter prior to administration to a patient.

  • Company:
    Baxter International Inc.
  • Problem
    Suffocation And Choking Hazards
Baxter Initiates U.S. Voluntary Recall of One Lot of Peritoneal Dialysis Solution Due to Container-Closure Non-Integrity
03/05/2014 Food Recall

Baxter International Inc. announced today it has initiated a voluntary recall in the United States of a single lot of DIANEAL PD-2 Peritoneal Dialysis Solution with 1.5% Dextrose 6000mL (Ambu-Flex II) to the hospital/user level. The recall is being initiated as a result of complaints of particulate matter, identified as mold, resulting from a leak in the container.

  • Company:
    Baxter International Inc.
  • Problem
    Suffocation And Choking Hazards
Baxter Initiates Nationwide Voluntary recall Of Select Lots of Premix Parenteral Nutrition
01/03/2014 Food Recall

Baxter International Inc. announced today it has initiated a voluntary recall in the United States of two lots of CLINIMIX and one lot of CLINIMIX E Injection parenteral nutrition products to the user level due to complaints of particulate matter found in the products.

  • Company:
    Baxter International Inc.
Nitroglycerin in 5% Dextrose Injection by Baxter: Recall - Particulate Matter
11/27/2013 Medical Recall

Voluntary recall of one lot due to particulate matter found in one vial. If infused, particulate matter could lead to potential venous and/or arterial thromboembolism.

  • Company:
    Baxter International Inc
Baxter Initiates Nationwide Voluntary Recall of One Lot of Nitroglycerin in 5% Dextrose Injection
11/27/2013 Food Recall

Baxter International Inc. announced today it has initiated a voluntary recall of one lot of Nitroglycerin in 5% Dextrose Injection due to particulate matter found in one vial. If infused, particulate matter could lead to potential venous and/or arterial thromboembolism (blockage of blood vessels.)

  • Company:
    Baxter International Inc.
  • Problem
    Shock Hazard
Baxter Dual Luer Lock Caps: Class I Recall - Presence of Loose Particulate Matter Found In Packaging
09/20/2013 Medical Recall

May result in thrombotic and embolic events, including: pulmonary embolism, myocardial infarction and stroke.

  • Company:
    Baxter International Inc.
Baxter Initiates Voluntary Recall of Two Lots of Dual Luer Lock Caps
09/19/2013 Food Recall

Baxter International Inc. announced today it has initiated a voluntary recall of two lots of its Dual Luer Lock Caps (Product Code 2C6250, Lots 10043 and 10044) because of the presence of loose particulate matter found in the packaging. Particulate matter entering the fluid path from the Luer Lock Caps may result in thrombotic and embolic events, including: pulmonary embolism, myocardial infarction and stroke.

  • Company:
    Baxter International Inc.